AB Science is a France-based pharmaceutical company that researches and develops novel therapeutics for the treatment of cancer, inflammatory and neurodegenerative disorders.
Business Model:
Revenue: $1.8M
Employees: 51-200
Address: 3, Avenue George V
City: Paris
State: île-de-france
Zip: 75008
Country: FR
AB Science is a France-based pharmaceutical company that researches and develops novel therapeutics for the treatment of cancer, inflammatory and neurodegenerative disorders.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
5/7/2010
Ticker Symbol:
AB
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2017 | Post-IPO Equity | $16.3M | 3/2017 | Equity | $16.3M | 1/2023 | Post-IPO Debt | $6.5M |
European Investment Bank |
1/2023 | Post-IPO Debt | 1 | $6.5M |
European Investment Bank European Investment Bank |
12/2022 | Post-IPO Debt | $6.4M |
European Investment Bank |
12/2022 | Post-IPO Debt | 1 | $6.4M |
European Investment Bank European Investment Bank |
4/2017 | Equity | $20.3M | 8/2019 | Post-IPO Equity | $11.1M | 2/2022 | Post-IPO Debt | $8.5M | 1/2023 | Post-IPO Debt | 1 | $6.5M |
European Investment Bank European Investment Bank |
12/2022 | Post-IPO Debt | 1 | $6.4M |
European Investment Bank European Investment Bank |
8/2019 | Post-IPO Equity | $11.1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|